DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCorporate Action

Morepen Laboratories Limited — Change in Directors/KMP/SMP/Auditor/RTA

NSE 1 hr ago·27 Oct 2026, 2:14 pm

Morepen LAB

Morepen Laboratories has informed stock exchanges about a change in its board of directors and key managerial personnel. The company has appointed a new Independent Director to its board. This move is a routine corporate governance update and does not signal any immediate operational changes or strategic shifts.

For investors, this news is generally neutral as it relates to administrative board composition. It is important to note that the company's core business operations and financial performance remain unaffected by this change in leadership.

Investors should monitor the company's future quarterly earnings reports to see if this new director brings any specific expertise or strategic focus that could impact the stock's performance in the long run.